Literature DB >> 24141526

Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation.

Verena Bröcker1, Michael Mengel.   

Abstract

ABO-compatible as well as ABO-incompatible kidney transplantation are well established in the pediatric population. There are particularities in the histopathological evaluation of pediatric kidney transplant biopsies as for example the recurrence of certain diseases different from the adult population. Furthermore, the challenging transition of pediatric renal transplant recipients to adulthood is associated with an increased rate of non-adherence triggered rejection episodes. With modern immunosuppressive drugs, T-cell-mediated rejection of renal allografts is well controlled. In contrast, antibody-mediated rejection (AMR) is increasingly recognized as one of the major reasons for allograft loss. However, the 2001 diagnostic Banff criteria for antibody-mediated rejection require further refinement, as the morphological spectrum of AMR expands while effective therapeutic strategies are lacking. For example, endarteritis, which traditionally has been attributed to T-cell-mediated rejection, has recently been shown to be part of the AMR spectrum in some cases. Many findings in transplant renal biopsies are not specific for a certain disease but need consideration of differential diagnoses. To use the term "chronic allograft nephropathy" as a diagnostic entity is no longer appropriate. Therefore, the precise identification of specific diseases is paramount in the assessment of transplant renal biopsies in order to enable tailored therapeutic management.

Entities:  

Mesh:

Year:  2013        PMID: 24141526     DOI: 10.1007/s00467-013-2640-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  71 in total

1.  Early loss of renal transcripts in kidney allografts: relationship to the development of histologic lesions and alloimmune effector mechanisms.

Authors:  G Einecke; G Broderick; B Sis; P F Halloran
Journal:  Am J Transplant       Date:  2007-05       Impact factor: 8.086

2.  Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts.

Authors:  M Mengel; J Reeve; S Bunnag; G Einecke; G S Jhangri; B Sis; K Famulski; L Guembes-Hidalgo; P F Halloran
Journal:  Am J Transplant       Date:  2009-06-26       Impact factor: 8.086

3.  Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.

Authors:  Qing Ding; Melissa Yeung; Geoffrey Camirand; Qiang Zeng; Hisaya Akiba; Hideo Yagita; Geetha Chalasani; Mohamed H Sayegh; Nader Najafian; David M Rothstein
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

4.  Banff initiative for quality assurance in transplantation (BIFQUIT): reproducibility of C4d immunohistochemistry in kidney allografts.

Authors:  M Mengel; S Chan; J Climenhaga; Y B Kushner; H Regele; R B Colvin; P Randhawa
Journal:  Am J Transplant       Date:  2013-03-06       Impact factor: 8.086

Review 5.  Histopathology of cyclosporine nephrotoxicity.

Authors:  M J Mihatsch; G Thiel; B Ryffel
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

Review 6.  Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients.

Authors:  Fabienne Dobbels; Rita Van Damme-Lombaert; Johan Vanhaecke; Sabina De Geest
Journal:  Pediatr Transplant       Date:  2005-06

7.  Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Authors:  B Sis; M Mengel; M Haas; R B Colvin; P F Halloran; L C Racusen; K Solez; W M Baldwin; E R Bracamonte; V Broecker; F Cosio; A J Demetris; C Drachenberg; G Einecke; J Gloor; D Glotz; E Kraus; C Legendre; H Liapis; R B Mannon; B J Nankivell; V Nickeleit; J C Papadimitriou; P Randhawa; H Regele; K Renaudin; E R Rodriguez; D Seron; S Seshan; M Suthanthiran; B A Wasowska; A Zachary; A Zeevi
Journal:  Am J Transplant       Date:  2010-01-29       Impact factor: 8.086

8.  The natural history of chronic allograft nephropathy.

Authors:  Brian J Nankivell; Richard J Borrows; Caroline L-S Fung; Philip J O'Connell; Richard D M Allen; Jeremy R Chapman
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

9.  Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

Authors:  Lorraine C Racusen; Robert B Colvin; Kim Solez; Michael J Mihatsch; Philip F Halloran; Patricia M Campbell; Michael J Cecka; Jean-Pierre Cosyns; Anthony J Demetris; Michael C Fishbein; Agnes Fogo; Peter Furness; Ian W Gibson; Denis Glotz; Pekka Hayry; Lawrence Hunsickern; Michael Kashgarian; Ronald Kerman; Alex J Magil; Robert Montgomery; Kunio Morozumi; Volker Nickeleit; Parmjeet Randhawa; Heinz Regele; Daniel Seron; Surya Seshan; Stale Sund; Kiril Trpkov
Journal:  Am J Transplant       Date:  2003-06       Impact factor: 8.086

Review 10.  Surveillance biopsies in children post-kidney transplant.

Authors:  Patricia E Birk
Journal:  Pediatr Nephrol       Date:  2011-07-27       Impact factor: 3.714

View more
  1 in total

1.  Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome.

Authors:  Laura A Michielsen; Arjan D van Zuilen; Tineke Kardol-Hoefnagel; Marianne C Verhaar; Henny G Otten
Journal:  Front Immunol       Date:  2018-05-14       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.